Click a link below to view the mailing archive as if it had been sent to you.
| 2025-02-28 12:15 | | Lilly hops on hot molecular glue train with $1.6B+ Magnet deal and more... |
| 2025-02-28 00:15 | | Eisai to part ways with 121 employees amid new US restructuring effort and more... |
| 2025-02-27 12:15 | | FDA committee meeting scrapped, reports say, in 2nd vaccine-related scheduling disruption in as many weeks and more... |
| 2025-02-27 00:15 | | Meeting of US FDA vaccine advisers canceled, committee member says and more... |
| 2025-02-26 12:15 | | Jazz 'active and looking' at M&A deals of 'various sizes' as it wraps up Epidiolex patent fights: execs and more... |
| 2025-02-26 00:15 | | Merck expects Keytruda to face HHS price setting in 2026 and more... |
| 2025-02-25 12:15 | | Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access and more... |
| 2025-02-25 00:15 | | In letter to RFK Jr., Democrats flag threats to drug review process from FDA firings and more... |
| 2025-02-24 12:15 | | Sanofi shows how $500M bowel disease bet compares to Merck and Roche's rival assets and more... |
| 2025-02-24 00:15 | | J&J’s fully subcutaneous Tremfya shows 27.6% clinical remission in UC and more... |
| 2025-02-21 12:15 | | Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara and more... |
| 2025-02-21 00:15 | | Eli Lilly Bets Big on Weight-Loss Pill With $550 Million Inventory Stockpile and more... |
| 2025-02-20 12:15 | | AstraZeneca deepens China presence with FibroGen deal and more... |
| 2025-02-20 00:15 | | Novartis, Roche grant CEO pay raises for 2024 as sales grew at the Swiss pharma giants and more... |
| 2025-02-19 12:15 | | Trump set to break WTO rules with potential pharma tariffs and more... |
| 2025-02-19 00:15 | | Merck Vaccine Trial Delayed as RFK Jr. Link Creates Jury Concern and more... |
| 2025-02-18 12:15 | | Novo seeks $830M in fraud case against Singaporean biotech over kidney drug and more... |
| 2025-02-17 00:15 | | Trump Administration Lays Off CDC’s Epidemic Intelligence Service Workers, Threatening Science And Public Health and more... |
| 2025-02-14 12:15 | | Moderna beats on revenue but loses more than expected as it scales down manufacturing and more... |
| 2025-02-14 00:15 | | Genentech archives diversity reports amid site update, examines ‘potential implications of executive orders’ and more... |
| 2025-02-13 12:15 | | Is J&J Going to Sell its Stroke Business? and more... |
| 2025-02-13 00:15 | | FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy and more... |
| 2025-02-12 12:15 | | Trump orders agencies to plan for ‘large-scale’ job cuts and more... |
| 2025-02-12 00:15 | | FDA approves SpringWorks' genetic disorder drug and more... |
| 2025-02-11 12:15 | | Novartis inks $925M Anthos takeover to buy back phase 3 clot-busting candidate and more... |
| 2025-02-11 00:15 | | Incyte's JAK cream Opzelura picks up steam as company works to revive Jakafi XR dreams and more... |
| 2025-02-10 12:15 | | NIH caps 'indirect costs' in biomedical research grants, aims to save $4B per year and more... |
| 2025-02-10 00:15 | | FDA approves AbbVie-Pfizer's treatment for intra-abdominal infections |
| 2025-02-07 12:15 | | Novo Nordisk plans new study for CagriSema, targets 2026 submission and more... |
| 2025-02-07 00:15 | | Vertex challenger Sionna prices $191M IPO and more... |
| 2025-02-06 12:15 | | Bristol Myers Squibb Tops Q4 Estimates and more... |
| 2025-02-06 00:15 | | Astellas takes $760M charge, reveals slowdown for eye drug Izervay after regulatory stumbles and more... |
| 2025-02-05 12:15 | | GSK Lifts Long-Term Outlook on Drug Pipeline, Buys Back Shares and more... |
| 2025-02-05 00:15 | | Bristol Myers Squibb, Kyowa Kirin layoffs hit 119 in New Jersey amid separate restructuring campaigns and more... |
| 2025-02-04 12:15 | | RFK Jr. clears key hurdle on path to become HHS secretary and more... |
| 2025-02-04 00:15 | | Lawmakers urge RFK Jr. to answer to Gardasil litigation conflict-of-interest concerns ahead of confirmation vote and more... |
| 2025-02-03 12:15 | | Pfizer's Braftovi combo on track for full approval in win for FDA's Project FrontRunner and more... |
| 2025-02-03 00:15 | | US government could seek over $1 billion from J&J for cancer treatment costs and more... |
